PE86099A1 - HYDRAZINE DERIVATIVES - Google Patents

HYDRAZINE DERIVATIVES

Info

Publication number
PE86099A1
PE86099A1 PE1998000576A PE00057698A PE86099A1 PE 86099 A1 PE86099 A1 PE 86099A1 PE 1998000576 A PE1998000576 A PE 1998000576A PE 00057698 A PE00057698 A PE 00057698A PE 86099 A1 PE86099 A1 PE 86099A1
Authority
PE
Peru
Prior art keywords
alkyl
aryl
alkynyl
refers
compounds
Prior art date
Application number
PE1998000576A
Other languages
Spanish (es)
Inventor
Daryl Simon Walter
Michael John Broadhurst
William Henry Johnson
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE86099A1 publication Critical patent/PE86099A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I) O SUS SALES, DONDE Y ES CO o SO2; R1 ES ALQUILO, ALQUENILO, CICLOALQUILO, ARILO, ENTRE OTROS; R2 ES ALQUILO, HALO-ALQUILO, ARILO-ALQUILO, ARILO-ALQUENILO, ENTRE OTROS; SI Y ES CO, R2 ES NR5R6; R3 ES H, ALQUILO OPCIONALMENTE SUSTITUIDO POR CIANO, AMINO, HIDROXI, ENTRE OTROS; o R2 Y R3 FORMAN JUNTOS UNA AMIDA, IMIDA, SULFONAMIDA O URETANO, TODOS CICLICOS DE 5-7 MIEMBROS; R4 ES ALQUILO, ALQUENILO, CICLOALQUILO, -(CH2)(1-2)-CH=CR7R8; X ES UN -(CH2)(1-5), -CH2-CH=CH-, -CH2-NHCO-, ENTRE OTROS; R5 Y R6 SON H, ALQUILO, ARILO-ALQUILO; R7 Y R8 JUNTOS SON ALQUILENO, EN EL QUE UN GRUPO METILENO ES REEMPLAZADO POR UN HETEROATOMO. UN COMPUESTO PREFERIDO ES (E)-2(R)-[1(S)-(HIDROXICARBAMOIL)-4-FENIL-3-BUTENIL]-2`-ISOBUTIL-2'-(METANOSULFONIL)4-METIL-VALEROHIDRAZIDA, ENTRE OTROS. TAMBIEN SE REFIERE A COMPUESTOS DE FORMULA (II) Y (IX), DONDE R9 ES TETRAHIDROPIRANILO, 4-METOXIBENCILO, BENCILO O TRI(ALQUILO-SILILO). TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I PUEDE SER UTIL PARA EL TRATAMIENTO DE LA INFLAMACION, FIEBRE, HEMORRAGIA, SEPSIS, ARTRITIS REUMATOIDE, OSTEOARTRITIS, ESCLEROSIS MULTIPLE O PSORIASIS AL SER UN INHIBIDOR DE LA LIBERACION DEL FACTOR DE NECROSIS TUMORAL (TNF O) Y DEL FACTOR DE CRECIMIENTO TRASFORMANTE (TGF O)IT REFERS TO COMPOUNDS OF FORMULA (I) OR ITS SALTS, WHERE AND IS CO or SO2; R1 IS ALKYL, ALKYNYL, CYCLOALKYL, ARYL, AMONG OTHERS; R2 IS ALKYL, HALO-ALKYL, ARYL-ALKYL, ARYL-ALKYNYL, AMONG OTHERS; IF Y IS CO, R2 IS NR5R6; R3 IS H, RENT OPTIONALLY SUBSTITUTED FOR CYAN, AMINO, HYDROXY, AMONG OTHERS; o R2 AND R3 TOGETHER AMIDA, IMIDA, SULFONAMIDA OR URETANO, ALL CYCLICS OF 5-7 MEMBERS; R4 IS ALKYL, ALKYNYL, CYCLLOALKYL, - (CH2) (1-2) -CH = CR7R8; X IS A - (CH2) (1-5), -CH2-CH = CH-, -CH2-NHCO-, AMONG OTHERS; R5 AND R6 ARE H, ALKYL, ARYL-ALKYL; TOGETHER R7 AND R8 ARE ALKYLENE, IN WHICH A METHYLENE GROUP IS REPLACED BY A HETEROATOM. A PREFERRED COMPOUND IS (E) -2 (R) - [1 (S) - (HIDROXICARBAMOIL) -4-FENIL-3-BUTENIL] -2`-ISOBUTIL-2 '- (METHANOSULFONIL) 4-METHYL-VALEROHYDRAZIDE, BETWEEN OTHERS. IT ALSO REFERS TO COMPOUNDS OF FORMULA (II) AND (IX), WHERE R9 IS TETRAHYDROPYRANYL, 4-METHOXYBENCIL, BENZYL OR TRI (ALKYL-SILYL). IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. COMPOUND I MAY BE USEFUL FOR THE TREATMENT OF INFLAMMATION, FEVER, HEMORRHAGE, SEPSIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, MULTIPLE SCLEROSIS, OR PSORIASIS BY BEING AN INJECTOR OF THE DELIVERY OF THE TUMORAL NECROSIS FACTOR (TGF O)

PE1998000576A 1997-06-30 1998-06-26 HYDRAZINE DERIVATIVES PE86099A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9713833.3A GB9713833D0 (en) 1997-06-30 1997-06-30 Novel hydrazine derivatives

Publications (1)

Publication Number Publication Date
PE86099A1 true PE86099A1 (en) 1999-09-17

Family

ID=10815174

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000576A PE86099A1 (en) 1997-06-30 1998-06-26 HYDRAZINE DERIVATIVES

Country Status (10)

Country Link
KR (1) KR100371122B1 (en)
AR (1) AR012258A1 (en)
CO (1) CO4940511A1 (en)
EA (1) EA199901111A1 (en)
GB (2) GB9713833D0 (en)
HR (1) HRP980366A2 (en)
PE (1) PE86099A1 (en)
UA (1) UA58561C2 (en)
YU (1) YU70899A (en)
ZA (1) ZA985469B (en)

Also Published As

Publication number Publication date
CO4940511A1 (en) 2000-07-24
UA58561C2 (en) 2003-08-15
YU70899A (en) 2002-06-19
ZA985469B (en) 1998-12-30
GB9713833D0 (en) 1997-09-03
AR012258A1 (en) 2000-09-27
HRP980366A2 (en) 1999-02-28
GB9803335D0 (en) 1998-04-15
EA199901111A1 (en) 2000-08-28
KR20010014331A (en) 2001-02-26
KR100371122B1 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
DK0613458T3 (en) Acyclic ethylenediamine derivatives as substance P receptor antagonists
BR1100514A (en) Process for the preparation of compounds derived from benzimidazoline - 2 - oxo - 1 - carboxylic acid; product / compound / composition
KR960703622A (en) PRODRUGS OF PROTEIN TYROSINE KINASE INHIBITORS
EG17123A (en) Hebicidal cyclohexane - 1,3 - dione derivatives.
NO20013808D0 (en) Anti-inflammatory indole derivatives
DE69228879D1 (en) AMIDINO DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS
ES2141137T3 (en) THERAPEUTIC AGENTS FOR PARKINSON'S DISEASE.
UY23657A1 (en) PROCEDURE FOR THE PREPARATION OF INDEOL DERIVATIVES
MX9300031A (en) DERIVATIVES OF PIPERAZINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ATE92485T1 (en) 3-(4-PIPERIDINE)-5-(2-SULPHONYLAMINOETHYL)-INDOLE DERIVATIVES.
PE86099A1 (en) HYDRAZINE DERIVATIVES
FI943931A0 (en) Indole derivatives as steroid-5alpha-reductase inhibitors
ES2080975T3 (en) SUBSTITUTED IMIDAZOL-2-ONA DERIVATIVES AND PREPARATION PROCEDURE.
SE8303913L (en) Heterocyclic Associations
ATE162191T1 (en) AZANORADAMANTANE
ES2037783T3 (en) PROCEDURE FOR OBTAINING SUBSTITUTED 3-AMINOSIDNONIMINES.
DK247784A (en) SPIRO (INDOLO (1,7-AB) (1,5) BENZODIAZEPINE-2,4'-PIPERIDINES), PROCEDURES FOR THE PRODUCTION THEREOF, AND INTERMEDIATES FOR USE THEREOF, AND THEIR USE AS MEDICINES
SG49680A1 (en) Medicament for the inducement of cognition enhancement
GB9315018D0 (en) Chemical compounds
PE20001300A1 (en) HYDRAZINE DERIVATIVES
GB2007648A (en) Benzylideneaniline and its Derivatives
IT1204460B (en) HETEROCYCLIC DERIVATIVES

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed